Erratum to: Cardiovasc Intervent Radiol (2015) 35:25–32 DOI 10.1007/s00270-014-1024-9
In the published article Fig. 3A and B are a duplicate of Figs. 1B and 2. The correct artworks of Fig. 3A and B appear below.
Freedom of reintervention (TLR and bypass surgery) of VIA (red) versus BMS (black) in SFA lesions of patients with symptomatic PAD at 24 months (TPP): A all patients: VIA 79.4 (95 % CI 0.70–0.90) versus BMS 73.0 % (95 % CI 0.63–0.85) (log rank p = 0.37) for VIABAHN® versus BMS, B in lesions ≥20 cm: VIA 80.0 (95 % CI 0.68–0.94) versus BMS 61.9 % (95 % CI 0.44–0.87) (log rank p = 0.13) for VIABAHN® versus BMS. Abbreviations as in Figs. 1 and 2. The numbers below are the patients at risk at 0, 6, 12, 18, and 24 months
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s00270-014-1024-9.
Rights and permissions
About this article
Cite this article
Lammer, J., Zeller, T., Hausegger, K.A. et al. Erratum to: Sustained Benefit at 2 Years for Covered Stents Versus Bare-Metal Stents in Long SFA Lesions: The VIASTAR Trial. Cardiovasc Intervent Radiol 38, 779–780 (2015). https://doi.org/10.1007/s00270-015-1070-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-015-1070-y